Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Medicinas Complementárias
Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
BMJ Open ; 10(8): e034431, 2020 08 20.
Artículo en Inglés | MEDLINE | ID: mdl-32819929

RESUMEN

INTRODUCTION: This clinical trial is designed to evaluate the effect of multiple-dose tranexamic acid (TXA) on perioperative blood loss in patients with rheumatoid arthritis (RA). METHODS AND ANALYSIS: A randomised, single-blinded, parallel-controlled study will be designed. Patients with RA (age 50-75 years) undergoing unilateral primary end-stage total knee arthroplasty will be randomly divided into group A or group B. Group A will be treated with one dose of TXA (1 g; intravenous injection 3 hours postsurgery) and group B with three doses (1 g; intravenous injection at 3, 6 and 12 hours postsurgery) after surgery. The primary outcomes will be evaluated with blood loss, maximum haemoglobin drop and transfusion rate. The secondary outcomes will be evaluated with knee function and complications. ETHICS AND DISSEMINATION: The Shanghai Guanghua Hospital of Integrated Traditional Chinese Medicine and Western Medicine Ethics Committee approved in this study in July 2019. Informed consent will be obtained from all participants. Results of the trial will be published in the Dryad and repository in a peer-reviewed journal. Additionally, deidentified data collected and analysed for this study will be available for review from the corresponding author on reasonable request. TRIAL REGISTRATION NUMBER: ChiCTR1900025013.


Asunto(s)
Antifibrinolíticos , Artritis Reumatoide , Artroplastia de Reemplazo de Rodilla , Ácido Tranexámico , Administración Intravenosa , Anciano , Artritis Reumatoide/tratamiento farmacológico , Artritis Reumatoide/cirugía , Pérdida de Sangre Quirúrgica/prevención & control , China , Humanos , Persona de Mediana Edad , Ensayos Clínicos Controlados Aleatorios como Asunto
2.
Int J Mol Sci ; 15(5): 7827-40, 2014 May 06.
Artículo en Inglés | MEDLINE | ID: mdl-24806341

RESUMEN

Ginseng is a popular herb for alleviating menopausal symptoms; however, no conclusive scientific data has shown ginseng as being efficient in such therapies. The present study was designed to evaluate the estrogenic efficacy of ginseng on reproductive target tissues of ovariectomized (OVX) mice. The OVX mice were treated with ginseng at doses of 12.0, 18.0 and 24.0 g/kg per day for four weeks. Ginseng treatments restored the estrus cycle and demonstrated significant estrogenic activity, as indicated by the reversal of the atrophy of the uterus and vagina, upregulation of estrogen receptor (ER) α and ER ß expression at the protein and mRNA level in the reproductive tissues, where ER α upregulation was stronger than that of ER ß. Meanwhile, treatment with ginseng significantly increased adrenal gland weight and serum estradiol and clearly decreased follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in circulation. Notably, the largest changes in these parameters were found at the highest dose of 24.0 g/kg. Moreover, ginseng at 18.0 g/kg resulted in the greatest decrease in weight gain caused by ovariectomy. The data suggest that ginseng estrogenic responses show tissue variation that reflects different affinities of ERs for ginseng components. This study demonstrates that ginseng activity is mediated through estrogenic components and provides further evidence for ginseng treatment of postmenopausal symptoms.


Asunto(s)
Estrógenos/uso terapéutico , Ovariectomía , Panax , Preparaciones de Plantas/uso terapéutico , Útero/efectos de los fármacos , Vagina/efectos de los fármacos , Animales , Estradiol/sangre , Estrógenos/química , Femenino , Hormona Luteinizante/sangre , Ratones , Tamaño de los Órganos/efectos de los fármacos , Ovario/cirugía , Panax/química , Fitoterapia , Preparaciones de Plantas/química , Receptores de Estrógenos/análisis , Receptores de Estrógenos/genética , Receptores de Estrógenos/metabolismo , Regulación hacia Arriba/efectos de los fármacos , Útero/patología , Vagina/patología
3.
Zhong Xi Yi Jie He Xue Bao ; 4(2): 175-80, 2006 Mar.
Artículo en Chino | MEDLINE | ID: mdl-16529695

RESUMEN

OBJECTIVE: To study the effects of Yiqi Huayu Recipe on neural cell adhesion molecule (N-CAM) in neuromuscular junctions during nerve regeneration in rats with lumbar nerve root compression. METHODS: The rats with lumbar nerve root compression were given Yiqi Huayu Recipe for 10, 20 and 30 days respectively. The distribution of N-CAM in neuromuscular junctions of soleus muscle in rats was examined with immunohistochemical method and confocal laser scanning microscopy technique. The acetylcholine receptor (AChR) was visualized with fluorescein-conjugated alpha-bungarotoxin (alpha-BTX). The overlap areas of N-CAM and AChR sites were measured with NIH image technique. RESULTS: The aggregates, sprouts and extensions of N-CAM in the neuromuscular junctions and the overlap areas of N-CAM and AChR sites in the Yiqi Huayu Recipe-treated group were all better improved than those in the untreated group. CONCLUSION: The expression of N-CAM is regulated according to the state of innervation for muscles. Yiqi Huayu Recipe may accelerate this nerve regeneration process.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Síndromes de Compresión Nerviosa/metabolismo , Moléculas de Adhesión de Célula Nerviosa/biosíntesis , Raíces Nerviosas Espinales , Animales , Animales Recién Nacidos , Masculino , Regeneración Nerviosa , Moléculas de Adhesión de Célula Nerviosa/genética , Unión Neuromuscular/metabolismo , Ratas , Ratas Sprague-Dawley , Receptores Colinérgicos/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA